EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

β-Lactam dosing in critically ill children: predictors for target non-attainment

Stef Schouwenburg iD, Tim Preijers iD, Roelie M Wösten-Van Asperen, Enno D Wildschut iD, Nelianne J Verkaik, Alan Abdulla iD, Matthijs de Hoog, Birgit C P Koch iD

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf457 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Stef Schouwenburg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Critical Illness, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Erasmus MC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction β-Lactam antibiotics are among the most frequently prescribed antibiotics on the paediatric ICU (PICU). For β-lactam antibiotics, unbound plasma concentrations above at least one to four times the MIC for 100% of the dosing interval (100% ƒT > 1–4×MIC) have been proposed as the pharmacodynamic target. This study aimed to determine target attainment of β-lactam antibiotics in PICUs and to identify predictors of target non-attainment. Patients and methods This prospective observational study was performed in two PICUs in the Netherlands. We enrolled paediatric patients treated with the following β-lactam antibiotics: cefotaxime, ceftazidime, ceftriaxone, cefuroxime, flucloxacillin and meropenem. The free concentration above the bacterial epidemiological cut-off minimum inhibitory concentration (ƒT > MICECOFF and ƒT > 4×MICECOFF) was determined. Secondary endpoints were estimated regression models for examining the association of target non-attainment with patient characteristics and clinical outcomes.

Results

A total of 116 patients were included, of whom 27.6% achieved 100% ƒT > MICECOFF and 13.7% achieved 100% ƒT > 4×MICECOFF. Regression analysis identified an estimated glomerular filtration rate (eGFR) ≥90 mL/min/1.73 m2 as a risk factor for target non-attainment. In addition, no significant association between the 100% ƒT > MICECOFF target attainment and ICU length of stay (LOS) was found. However, for both pharmacodynamic targets, a significant correlation was found between LOS and age in years.

Conclusions

This study found an eGFR ≥90 mL/min/1.73 m2 to be associated with target non-attainment, indicating that kidney function should be taken into account when identifying individuals who may require higher dosages. These results may help identify subpopulations of paediatric patients requiring higher dosages or continuous infusion in order to achieve adequate β-lactam exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessAnti-Bacterial Agentsbeta-LactamsHumansProspective StudiesMaleFemaleChildChild, PreschoolMicrobial Sensitivity TestsInfantNetherlandsIntensive Care Units, PediatricAdolescentGlomerular Filtration Rate

Substanzen

Anti-Bacterial Agentsbeta-Lactams

Autor:innen und Institutionen

  • Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Rotterdam Clinical Pharmacometrics Group, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Department of Pediatric Intensive Care, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.
  • Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Stef Schouwenburg, Tim Preijers, Enno D Wildschut, Alan Abdulla, Birgit C P Koch

Förderung

  • Erasmus MC

Zitieren

APA

Schouwenburg, S., Preijers, T., Wösten-Van Asperen, R. M., Wildschut, E. D., Verkaik, N. J., Abdulla, A., de Hoog, M., & Koch, B. C. P. (2026). β-Lactam dosing in critically ill children: predictors for target non-attainment. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf457

Vancouver

Schouwenburg S, Preijers T, Wösten-Van Asperen RM, Wildschut ED, Verkaik NJ, Abdulla A, et al. β-Lactam dosing in critically ill children: predictors for target non-attainment. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf457

BibTeX
@article{Schouwenburg2026,
  author = {Schouwenburg, Stef and Preijers, Tim and Wösten-Van Asperen, Roelie M and Wildschut, Enno D and Verkaik, Nelianne J and Abdulla, Alan and de Hoog, Matthijs and Koch, Birgit C P},
  title = {β-Lactam dosing in critically ill children: predictors for target non-attainment},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf457}
}
Kostenlos starten →